Matthew Bennett Arnold serves as Executive at Solid Biosciences Inc., where they oversee executive responsibilities. Since joining the company, Matthew Bennett Arnold has executed 6 insider transactions totaling $310.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 10, 2020 involved receiving (via award) 432,432 shares valued at $1.6M.
Matthew Bennett Arnold currently holds 3,933,429 shares of Solid Biosciences Inc. (SLDB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Bennett Arnold has been a net seller of SLDB stock. They have purchased $0 and sold $310.4K worth of shares.
Matthew Bennett Arnold's most recent insider trade was on Dec 10, 2020, when they sold 432,432 shares at $3.70 per share.
Get notified when new Form 4 filings are submitted
| $4.65 |
| Discretionary |
| Jun 14, 2019 | SLDB | $0 | Gift | 562,715 | $N/A | Discretionary |
| Jan 14, 2019 | SLDB | $53.7K | Sale | 1,700 | $31.60 | Discretionary |
| Jan 14, 2019 | SLDB | $106.3K | Sale | 3,300 | $32.20 | Discretionary |
| Jan 7, 2019 | SLDB | $150.4K | Sale | 5,000 | $30.08 | Discretionary |